"Biological Products" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay.
| Descriptor ID |
D001688
|
| MeSH Number(s) |
D20.215
|
| Concept/Terms |
Biological Products- Biological Products
- Biologic Products
- Products, Biologic
- Biologics
- Products, Biological
|
Below are MeSH descriptors whose meaning is more general than "Biological Products".
Below are MeSH descriptors whose meaning is more specific than "Biological Products".
This graph shows the total number of publications written about "Biological Products" by people in this website by year, and whether "Biological Products" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biological Products" by people in Profiles.
-
Incidence and risk factors associated with a syndrome of persistent cytopenias after CAR-T cell therapy (PCTT). Leuk Lymphoma. 2020 04; 61(4):940-943.
-
Orthobiologics for Focal Articular Cartilage Defects. Clin Sports Med. 2019 Jan; 38(1):109-122.
-
Patient-reported outcomes in lupus clinical trials with biologics. Lupus. 2016 Sep; 25(10):1111-21.
-
IBD LIVE Case Series-Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment? Inflamm Bowel Dis. 2015 Jun; 21(6):1401-6.
-
Approach to the tricyclic core of the tigliane-daphnane diterpenes. Concerning the utility of transannular aldol additions. Org Lett. 2013 Jul 05; 15(13):3330-3.
-
A macrocyclic approach to tetracycline natural products. Investigation of transannular alkylations and Michael additions. Org Lett. 2012 Dec 07; 14(23):5840-3.
-
Sequential administration of bovine and human adenovirus vectors to overcome vector immunity in an immunocompetent mouse model of breast cancer. Virus Res. 2012 Jan; 163(1):202-11.
-
Intervertebral disk repair by protein, gene, or cell injection: a framework for rehabilitation-focused biologics in the spine. PM R. 2011 Jun; 3(6 Suppl 1):S88-94.
-
Biologic generics. Am J Ther. 2007 May-Jun; 14(3):230.
-
Are we moving forward in the biological treatment of Crohn's disease? Time will tell. Inflamm Bowel Dis. 2006 Feb; 12(2):147-9.